Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study-Reference-Cited by-同舟云学术

Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

Published:2023-08 Issue:8 Volume:23 Page:914-921
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Arbel Ronen,Peretz Alon,Sergienko Ruslan,Friger Michael,Beckenstein Tanya,Duskin-Bitan Hadar,Yaron Shlomit,Hammerman Ariel,Bilenko Natalya,Netzer Doron

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference21 articles.

1. A bivalent omicron-containing booster vaccine against COVID-19;Chalkias;N Engl J Med,2022

2. Safety and efficacy of a third dose of BNT162b2 COVID-19 vaccine;Moreira;N Engl J Med,2022

3. New boosters are here! Who should receive them and when?;Doron;Lancet Infect Dis,2022

4. Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting;Magen;N Engl J Med,2022

5. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years;Arbel;Nat Med,2022

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants;Journal of Infection;2024-10

2. Comparative effectiveness of bivalent BA.4–5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study;Journal of Infection;2024-10

3. Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023;Eurosurveillance;2024-09-12

4. Public Health and Economic Impact of Periodic COVID-19 Vaccination with BNT162b2 for Old Adults and High-Risk Patients in an Illustrative Prefecture of Japan: A Budget Impact Analysis;Infectious Diseases and Therapy;2024-09-10

5. Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques;iScience;2024-09